Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Fumiaki IKEGAMI"'
Autor:
Akihiro Inano, Koichi Nakamura, Kazumichi Abe, Kimio Terao, Akihiro Ohnishi, Sumire Shimada, Hiromasa Ohira, Atsushi Takahashi, Kumiko Miyata, Haruki Yamada, Tomohisa Saito, Fumiaki Ikegami, Yasuhiro Ohba
Publikováno v:
Drug research. 70(9)
Background Tofogliflozin is a highly selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. A mass balance study with combinations of microdoses revealed that tofogliflozin has high oral bioavailability (97.5%) and that tofogliflozin in circula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b2003f44a38cf14e829f9e59243aeb3
https://pubmed.ncbi.nlm.nih.gov/32707593
https://pubmed.ncbi.nlm.nih.gov/32707593
Publikováno v:
International Journal of Hydrogen Energy. 42:19733-19743
Ni Ru bimetallic catalysts with different amount of CeO2 loaded on the γ-Al2O3 support were prepared. The properties of catalysts were characterized by means of N2 adsorption-desorption, XRD, H2-TPR and XPS techniques. Catalytic activities for the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5357c683936d2ba1609a3a3a2e46bff8
https://doi.org/10.1016/j.ijhydene.2017.06.120
https://doi.org/10.1016/j.ijhydene.2017.06.120
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 38:81-88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59105c32f567368b569e9b604ac5da5a
https://doi.org/10.3999/jscpt.38.81
https://doi.org/10.3999/jscpt.38.81
Autor:
Haruhiko Yoshida, Osamu Yokosuka, Tetsuro Katamoto, Akira Nakamura, Ryo Nakata, Masao Omata, Yasushi Shiratori, Fumiaki Ikegami, Masashi Ihori, Fumio Imazeki, Naoya Kato, Katsutaro Hirota, Tateo Kawase, Tadao Unuma
Publikováno v:
Digestive Diseases and Sciences. 45:565-574
Adequate dosing of interferon (IFN) and its cost-effectiveness for sustained virological response were evaluated in relation to viral load and subtype. Prospective analysis of IFN therapy on 326 patients with chronic hepatitis C free from cirrhosis w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdb52110b55613dce04c6403426abbb5
https://doi.org/10.1023/a:1005457510354
https://doi.org/10.1023/a:1005457510354
Autor:
Hirohito Tsubouchi, Yoshiki Sugai, Kunihiko Hino, Tsunehisa Kawasaki, Naofumi Ohno, Yasunori Takehira, Tatsuya Aikawa, Fumiaki Ikegami, Makoto Mayumi, Kazuro Masuko, K. Iwata, Makoto Kako, Takeyuki Nakajima, Takashi Kumada, Hiroshi Maekubo, Mineo Kojima, Koichi Kanai, Satoshi Tanaka, Masaru Shimizu
Publikováno v:
Kanzo. 41:254-261
B型慢性肝炎159例に対しIFN-α2aを26～50週間投与した. HBe抗原陽性群はIFN24週投与後に24.7%でHBe抗原が陰性化し, そのうち80%の症例はその後もHBe抗原陰性が持続した. 24週でHBe抗原陽性でさらに
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4999ffb524b9a20c41221b6a046acdc4
https://doi.org/10.2957/kanzo.41.254
https://doi.org/10.2957/kanzo.41.254
Autor:
Shuichi Sezai, Takashi Abe, Kazuaki Kamisaka, Fumiaki Ikegami, Yoshihiro Yamamoto, Masayoshi Ito, Yukihiro Sakurai, Masanori Hirano
Publikováno v:
Digestive Diseases and Sciences. 43:1302-1306
We evaluated the gastric circulatory effects of the type of treatment administered for portal hypertension. Of 14 patients with cirrhosis, seven received a transjugular intrahepatic portosystemic shunt (TIPS; group T) and seven received percutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d4c933e4874ccbb331d4a9a0f56ae34
https://doi.org/10.1023/a:1018872227652
https://doi.org/10.1023/a:1018872227652
Autor:
Masayoshi Ito, Shuichi Sezai, Fumiaki Ikegami, Takashi Abe, Yasuki Kobayashi, Yukihiro Sakurai, Takanori Ohyama, Kazuaki Kamisaka
Publikováno v:
Digestive Diseases and Sciences. 43:1521-1525
Colonic diverticula have been generally acceptedas a source of massive hemorrhaging. Little is known,however, about fecal occult blood loss from colonicdiverticula and diverticulosis. We retrospectively investigated the possibility of minor bleedingi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b66a25c3dd4a0f261f16dedcefce8e5
https://doi.org/10.1023/a:1018866915782
https://doi.org/10.1023/a:1018866915782
Publikováno v:
American Journal of Hypertension. 10:886-892
To assess the effect of antihypertensive therapy on hemorheology in essential hypertension, blood viscosity and red blood cell deformability were examined in 45 patients with essential hypertension and 20 age-matched normotensive control subjects. Hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2ecc262b3c0d6df9d058272a3f35c2
https://doi.org/10.1016/s0895-7061(97)00095-2
https://doi.org/10.1016/s0895-7061(97)00095-2
Autor:
Kazuaki Kamisaka, Fumiaki Ikegami, Masahiro Oota, Shuichi Sezai, Yukihiro Sakurai, Toshiyuki Baba, Takahiro Ooyama, Takashi Abe, Yujirou Tanaka, Mitsuhiro Terada, Masayoshi Ito
Publikováno v:
Kanzo. 38:355-360
C型慢性肝炎に対し, インターフェロン (IFN) 治療を施行し, 治療終了後2年以上, 平均44カ月間定期的に経過観察されている371例を対象に肝細胞癌の発生率を検討した. 著効群 (治療終了6カ月
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccf60ebdf810c41ab7a3edc017aa404e
https://doi.org/10.2957/kanzo.38.355
https://doi.org/10.2957/kanzo.38.355
Autor:
Kazuaki Kamisaka, Yukihiro Sakurai, Masayoshi Ito, Takashi Abe, Masahiro Oota, Mitsuhiro Terada, Fumiaki Ikegami, Takahiro Ooyama, Yujiro Tanaka, Shuichi Sezai
Publikováno v:
Kanzo. 38:134-139
初回500MU以上のIFN治療が施行され, 治療終了12カ月以内にALTの再上昇を認めた30例に対し, IFN 1回6MUを3回/週, 24週 (17例) 及び48週 (13例) の再治療を施行し, その治療成績を検討した. 完全著効
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d9d24fd297d46007648a3caefd1945
https://doi.org/10.2957/kanzo.38.134
https://doi.org/10.2957/kanzo.38.134